Zacks Investment Research
13 Jul 2026, 14:55 UTC · 8h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Wall Street analysts have a mean price target of $17.29 for Lumexa (LMRI), representing a 44.1% potential upside from its current price of $12. — A significant positive analyst consensus generally attracts buyers and boosts short-term price momentum.
+0.40There is strong agreement among analysts that Lumexa is likely to report better earnings than previously predicted. — Positive earnings estimate revisions are a strong fundamental signal for potential stock price increases.
+0.30Lumexa's stock price has gained 24.5% over the past four weeks. — Recent positive price action indicates established bullish momentum.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The stock has gained 24.5% over four weeks and has a mean price target indicating significant upside potential.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
33m ago
